We serve Chemical Name:3-(2-chloro-3,4-dimethoxyphenyl)prop-2-enoyl chloride CAS:175136-00-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-(2-chloro-3,4-dimethoxyphenyl)prop-2-enoyl chloride
CAS.NO:175136-00-2
Synonyms:2-Propenoyl chloride,3-(2-chloro-3,4-dimethoxyphenyl);3-(2-CHLORO-3,4-DIMETHOXYPHENYL)ACRYLOYL CHLORIDE
Molecular Formula:C11H10Cl2O3
Molecular Weight:261.10100
HS Code:2918990090
Physical and Chemical Properties:
Melting point:86ºC
Boiling point:375.3ºC at 760mmHg
Density:1.312g/cm3
Index of Refraction:1.57
PSA:35.53000
Exact Mass:260.00100
LogP:3.13580
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Propenoyl chloride,3-(2-chloro-3,4-dimethoxyphenyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(2-CHLORO-3,4-DIMETHOXYPHENYL)ACRYLOYL CHLORIDE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Propenoyl chloride,3-(2-chloro-3,4-dimethoxyphenyl) Use and application,3-(2-CHLORO-3,4-DIMETHOXYPHENYL)ACRYLOYL CHLORIDE technical grade,usp/ep/jp grade.
Related News: The QbD studies were designed concisely to minimize the use of the API and evaluate the critical product parameters that could affect the product quality attributes of the drug product, per FDA’s QbD guidance. 3-Bromo-1-(triisopropylsilyl)-1H-pyrrole manufacturers The QbD studies were designed concisely to minimize the use of the API and evaluate the critical product parameters that could affect the product quality attributes of the drug product, per FDA’s QbD guidance. Dynorphin A (1-9) suppliers Another critically important benefit of biocatalytic processes is that they are far more eco-efficient than conventional methods. This is because enzymes, being originally derived from natural products, generally perform best under mild (often ambient) conditions. 2-(2-Biphenylyloxy)ethyl acrylate vendor & factory It’s official. Nearly two years after the FDA granted conditional approval to Merck’s Keytruda and Eisai’s Lenvima for endometrial cancer, the U.S. regulator has blessed the combination therapy, with no strings attached.,“In the past few years, the pharmaceutical industry has seen rapid growth driven by the growth of small molecules’ innovations, complex APIs and the increasing need to optimize available resources.
